In this issue: When memory changes are not Alzheimer’s disease: how to tell the difference

Dorene Rentz, PsyD, is a Professor of Neurology at Harvard Medical School and a clinical neuropsychologist with dual appointments in the Departments of Neurology at Brigham and Women’s Hospital and Massachusetts General Hospital. She serves as the Co-Director of the Center for Alzheimer Research and Treatment and the Director of the Outreach, Retention and Engagement Core at the Massachusetts Alzheimer’s Disease Research Center. She is also the Clinical Core Leader of the Harvard Aging Brain study and Co- Leader of the Clinical Outcome Instrument Unit of the Alzheimer Clinical Trial Consortium. Her Research focus has been on the early detection of preclinical Alzheimer’s disease, particularly in high functioning individuals. Her recent work involves exploring early cognitive changes using PET amyloid and tau imaging. More recently, she is a leader in cognitive outcome assessments for secondary prevention trials in Preclinical Alzheimer’s disease and has explored the feasibility of using technology to do cognitive assessments in the clinic and home environments

Share this page: